procarbazine has been researched along with Leukopenia in 42 studies
Procarbazine: An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease.
procarbazine : A benzamide obtained by formal condensation of the carboxy group of 4-[(2-methylhydrazino)methyl]benzoic acid with the amino group of isopropylamine. An antineoplastic chemotherapy drug used for treatment of Hodgkin's lymphoma. Metabolism yields azo-procarbazine and hydrogen peroxide, which results in the breaking of DNA strands.
Leukopenia: A decrease in the number of LEUKOCYTES in a blood sample below the normal range (LEUKOCYTE COUNT less than 4000).
| Excerpt | Relevance | Reference |
|---|---|---|
| "We undertook a phase II study of combination chemotherapy with mechlorethamine (nitrogen mustard) 6 mg/m2 intravenously day 1 and day 8, vincristine 2 mg intravenously day 1 and day 8, and procarbazine 100 mg/m2 orally days 1 through 14 (MOP) in adults with recurrent high-grade glioma." | 9.06 | Mechlorethamine, vincristine, and procarbazine chemotherapy for recurrent high-grade glioma in adults: a phase II study. ( Baptista, J; Clark, K; Coyle, T; Graziano, S; King, R; Kirshner, J; Newman-Palmer, N; Poiesz, B; Scalzo, A; Winfield, J, 1990) |
| "Thirty patients with disseminated cutaneous malignant melanoma were treated with a three-drug cytotoxic chemotherapy program consisting of CCNU, procarbazine, and vincristine." | 7.66 | Combination cytotoxic chemotherapy with CCNU, procarbazine, and vincristine in disseminated cutaneous malignant melanoma: 3 years, followup. ( Carmo-Pereira, J; Costa, FO; Henriques, E; Pimentel, P, 1980) |
| "We undertook a phase II study of combination chemotherapy with mechlorethamine (nitrogen mustard) 6 mg/m2 intravenously day 1 and day 8, vincristine 2 mg intravenously day 1 and day 8, and procarbazine 100 mg/m2 orally days 1 through 14 (MOP) in adults with recurrent high-grade glioma." | 5.06 | Mechlorethamine, vincristine, and procarbazine chemotherapy for recurrent high-grade glioma in adults: a phase II study. ( Baptista, J; Clark, K; Coyle, T; Graziano, S; King, R; Kirshner, J; Newman-Palmer, N; Poiesz, B; Scalzo, A; Winfield, J, 1990) |
| "Twelve patients with relapsed or refractory malignant lymphoma were treated with IMV-triple P regimen consisting of ifosfamide (IFM), mitoxantrone (MIT), vindesine (VDS), pepleomycin (PEP), procarbazine (PCZ) and prednisolone (PDN)." | 3.68 | [Salvage chemotherapy with IMV-triple P for relapsed or refractory malignant lymphoma]. ( Arai, N; Hara, A; Shirai, T; Umeda, M, 1991) |
| "Thirty patients with disseminated cutaneous malignant melanoma were treated with a three-drug cytotoxic chemotherapy program consisting of CCNU, procarbazine, and vincristine." | 3.66 | Combination cytotoxic chemotherapy with CCNU, procarbazine, and vincristine in disseminated cutaneous malignant melanoma: 3 years, followup. ( Carmo-Pereira, J; Costa, FO; Henriques, E; Pimentel, P, 1980) |
| "To improve survival of elderly patients with primary central nervous system lymphoma (PCNSL), we conducted a phase II study with high-dose methotrexate (MTX) combined with procarbazine and CCNU." | 2.74 | High-dose methotrexate combined with procarbazine and CCNU for primary CNS lymphoma in the elderly: results of a prospective pilot and phase II study. ( Deckert, M; Feuerhake, F; Finke, J; Ihorst, G; Illerhaus, G; Marks, R; Müller, F; Ostertag, C, 2009) |
| " Despite increased hematotoxicity, moderate dose escalation is safe for the majority of the patients with G-CSF assistance and standard supportive treatment." | 2.69 | Acute hematologic toxicity and practicability of dose-intensified BEACOPP chemotherapy for advanced stage Hodgkin's disease. German Hodgkin's Lymphoma Study Group (GHSG). ( Diehl, V; Engel, C; Loeffler, M; Schmitz, S; Tesch, H, 2000) |
| "However, leukocytopenia was observed in many patients despite combined use of G-CSF, suggesting the dose and administration method of THP should be studied further." | 2.68 | [Usefulness of THP-COPBLM therapy in elderly patients with non-Hodgkin's lymphoma]. ( Nakayama, M; Niitsu, N; Umeda, M, 1997) |
| "Thirty-four children with Hodgkin's disease were treated during the years 1969--75." | 2.64 | MVPP chemotherapy combined with radiotherapy in the treatment of Hodgkin's disease in children. ( Armata, J; Borkowski, W; Depowska, T; Depowski, M; Kaczor, Z; Stopyrowa, J; Strzeszynski, J, 1978) |
| "Although G-CSF is widely used to prevent or ameliorate leukopenia during cytotoxic chemotherapies, its optimal use is still under debate and depends on many therapy parameters such as dosing and timing of cytotoxic drugs and G-CSF, G-CSF pharmaceuticals used and individual risk factors of patients." | 1.48 | Model-based optimization of G-CSF treatment during cytotoxic chemotherapy. ( Engel, C; Loeffler, M; Loibl, S; Schirm, S; Scholz, M, 2018) |
| "Of 6 patients who developed recurrence, 3 (7." | 1.33 | [Comparison of preliminary results of involved-field with extended field radiotherapy combined with chemotherapy for early stage Hodgkin's disease]. ( Han, JZ; Jin, J; Li, YX; Liu, XF; Liu, YP; Song, YW; Wang, SL; Wang, WH; Yu, ZH; Zhou, LQ, 2006) |
| " The optimal dosing for MV26PD remains to be determined." | 1.27 | Treatment of refractory lymphoma with methotrexate, VM-26 (teniposide), procarbazine, and dexamethasone: Cancer and Leukemia Group B study 7902. ( Anderson, J; Bloomfield, CD; Cooper, MR; Ginsberg, SJ; Gottlieb, AJ; Hurd, DD; Lachant, NA, 1988) |
| "One patient with Hodgkin's disease involving the liver is alive at 36 months with further therapy." | 1.26 | Adriamycin, bleomycin, DIC, CCNU, and prednisone (ABDIC) chemotherapy in MOPP-resistant Hodgkin's disease. ( Gamble, JF; Loh, KK; Rodgers, RW; Shullenberger, CC, 1980) |
| "Thirty-eight patients with advanced Hodgkin's disease were treated with a combination of cyclophosphamide, vinblastine, procarbazine, and prednisone (CVPP)." | 1.26 | Combinaed chemotherapy with cyclophosphamide, vinblastine, procarbazine, and prednisone (CVPP) for patients with advanced Hodgkin's disease. An alternative program to MOPP. ( Bloomfield, CD; Fortuny, I; Kennedy, BJ; Vosika, G; Weiss, RB, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 27 (64.29) | 18.7374 |
| 1990's | 7 (16.67) | 18.2507 |
| 2000's | 7 (16.67) | 29.6817 |
| 2010's | 1 (2.38) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schirm, S | 1 |
| Engel, C | 2 |
| Loibl, S | 1 |
| Loeffler, M | 2 |
| Scholz, M | 1 |
| Illerhaus, G | 1 |
| Marks, R | 1 |
| Müller, F | 1 |
| Ihorst, G | 1 |
| Feuerhake, F | 1 |
| Deckert, M | 1 |
| Ostertag, C | 1 |
| Finke, J | 1 |
| Niu, Y | 1 |
| Shi, YK | 1 |
| He, XH | 1 |
| Feng, FY | 1 |
| Zhou, LQ | 2 |
| Gu, DZ | 1 |
| Zander, T | 1 |
| Nettekoven, W | 1 |
| Kraus, JA | 1 |
| Pels, H | 1 |
| Ko, YD | 1 |
| Vetter, H | 1 |
| Klockgether, T | 1 |
| Schlegel, U | 1 |
| Sieber, M | 1 |
| Bredenfeld, H | 1 |
| Josting, A | 1 |
| Reineke, T | 1 |
| Rueffer, U | 1 |
| Koch, T | 1 |
| Naumann, R | 1 |
| Boissevain, F | 1 |
| Koch, P | 1 |
| Worst, P | 1 |
| Soekler, M | 1 |
| Eich, H | 1 |
| Müller-Hermelink, HK | 1 |
| Franklin, J | 1 |
| Paulus, U | 1 |
| Wolf, J | 1 |
| Engert, A | 1 |
| Diehl, V | 2 |
| Yamanaka, R | 1 |
| Morii, K | 1 |
| Shinbo, Y | 1 |
| Takeuchi, S | 1 |
| Tamura, T | 1 |
| Hondoh, H | 1 |
| Takahashi, H | 2 |
| Onda, K | 1 |
| Tanaka, R | 1 |
| Wang, WH | 1 |
| Li, YX | 1 |
| Song, YW | 1 |
| Jin, J | 1 |
| Liu, YP | 1 |
| Wang, SL | 1 |
| Liu, XF | 1 |
| Yu, ZH | 1 |
| Han, JZ | 1 |
| Rodgers, RW | 1 |
| Gamble, JF | 2 |
| Loh, KK | 1 |
| Shullenberger, CC | 2 |
| Aisner, J | 1 |
| Whitacre, M | 1 |
| Van Echo, DA | 1 |
| Wiernik, PH | 1 |
| Armata, J | 2 |
| Cyklis, R | 1 |
| Grześkowiak-Melanowska, J | 1 |
| Fisher, RI | 1 |
| DeVita, VT | 1 |
| Hubbard, SM | 1 |
| Longo, DL | 1 |
| Wesley, R | 1 |
| Chabner, BA | 1 |
| Young, RC | 1 |
| Wagener, DJ | 1 |
| Burgers, JM | 1 |
| Dekker, AW | 1 |
| Kazem, I | 1 |
| van Peperzeel, HA | 1 |
| Qasim, MM | 1 |
| Sizoo, W | 1 |
| Somers, R | 1 |
| Kroese, WF | 1 |
| Sweet, DL | 1 |
| Golomb, HM | 1 |
| Carmo-Pereira, J | 1 |
| Costa, FO | 1 |
| Pimentel, P | 1 |
| Henriques, E | 1 |
| Canellos, GP | 1 |
| Petroni, GR | 1 |
| Barcos, M | 1 |
| Duggan, DB | 1 |
| Peterson, BA | 1 |
| Niitsu, N | 2 |
| Hara, A | 3 |
| Umeda, M | 4 |
| Shirai, T | 3 |
| Nakayama, M | 1 |
| Dunlop, DJ | 1 |
| Eatock, MM | 1 |
| Paul, J | 1 |
| Anderson, S | 1 |
| Reed, NS | 1 |
| Soukop, M | 1 |
| Lucie, N | 1 |
| Fitzsimmons, EJ | 1 |
| Tansey, P | 1 |
| Steward, WP | 1 |
| Schmitz, S | 1 |
| Tesch, H | 1 |
| Hansen, HH | 1 |
| Selawry, OS | 1 |
| Simon, R | 1 |
| Carr, DT | 1 |
| van Wyk, CE | 1 |
| Tucker, RD | 1 |
| Sealy, R | 1 |
| Stopyrowa, J | 1 |
| Depowski, M | 1 |
| Strzeszynski, J | 1 |
| Borkowski, W | 1 |
| Kaczor, Z | 1 |
| Depowska, T | 1 |
| Hartwich, G | 1 |
| Neidhardt, B | 1 |
| Bloomfield, CD | 2 |
| Weiss, RB | 1 |
| Fortuny, I | 1 |
| Vosika, G | 1 |
| Kennedy, BJ | 1 |
| de Kreek, EJ | 1 |
| Sybesma, HB | 1 |
| Arai, N | 2 |
| Coyle, T | 1 |
| Baptista, J | 1 |
| Winfield, J | 1 |
| Clark, K | 1 |
| Poiesz, B | 1 |
| Kirshner, J | 1 |
| Scalzo, A | 1 |
| Newman-Palmer, N | 1 |
| King, R | 1 |
| Graziano, S | 1 |
| Lachant, NA | 1 |
| Anderson, J | 1 |
| Ginsberg, SJ | 1 |
| Cooper, MR | 1 |
| Hurd, DD | 1 |
| Gottlieb, AJ | 1 |
| Abate, G | 1 |
| Comella, P | 1 |
| Di Pietro, N | 1 |
| Ganzina, F | 1 |
| Pergola, M | 1 |
| Silvestro, P | 1 |
| Basso, A | 1 |
| Salvatore, M | 1 |
| Zarrilli, D | 1 |
| Lehnert, M | 1 |
| Biffl, G | 1 |
| Wascher, H | 1 |
| Jordis-Lohausen, K | 1 |
| Wählby, S | 1 |
| Ezdinli, EZ | 1 |
| Anderson, JR | 1 |
| Melvin, F | 1 |
| Glick, JH | 1 |
| Davis, TE | 1 |
| O'Connell, MJ | 1 |
| Mechl, Z | 1 |
| Krejcí, P | 1 |
| Dold, U | 1 |
| Desser, RK | 1 |
| Ultmann, JE | 1 |
| Stenzel, L | 1 |
| Krug, K | 1 |
| Schingnitz, G | 1 |
| Sacks, P | 1 |
| Jacobs, P | 1 |
| Gale, D | 1 |
| Lynch, SR | 1 |
| Bothwell, TH | 1 |
| Stevens, K | 1 |
| Vasantha Kumar, AR | 1 |
| Renaudin, J | 1 |
| Wilson, CB | 1 |
| Boldrey, EB | 1 |
| Enot, KJ | 1 |
| Levin, VA | 1 |
| Host, H | 1 |
| Abrahamsen, AF | 1 |
| Mubashir, BA | 1 |
| Fairley, GH | 1 |
| Mukherji, B | 1 |
| Oettgen, HF | 1 |
| Yagoda, A | 1 |
| Krakoff, IH | 1 |
| Floersheim, GL | 1 |
| Brune, K | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Treatment of Patients Over 65 Years With Primary CNS Lymphoma: High-dose Methotrexate Combined With Chemo-immunotherapy Followed by Maintenance Therapy[NCT00989352] | Phase 2 | 56 participants (Anticipated) | Interventional | 2009-09-30 | Recruiting | ||
| A Prospective, Open, Randomized Controlled, Multi-center Phase III Clinical Trial Comparing High-dose Epirubicin and Standard-dose Epirubicin in R±CEOP in Newly Diagnosed Young Patients With Medium/High-risk Diffuse Large B-cell Lymphoma[NCT03151044] | Phase 3 | 408 participants (Anticipated) | Interventional | 2016-07-31 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for procarbazine and Leukopenia
| Article | Year |
|---|---|
[Chemotherapy of malignant lymphomas].
Topics: Cyclophosphamide; Drug Therapy, Combination; Hodgkin Disease; Humans; Leukopenia; Lymphoma; Neoplasm | 1978 |
The sensitivity of Hodgkin's disease to chemotherapeutic agents administered singly.
Topics: Adrenal Cortex Hormones; Alopecia; Antineoplastic Agents; Bleomycin; Blood Platelet Disorders; Carmu | 1973 |
11 trials available for procarbazine and Leukopenia
| Article | Year |
|---|---|
High-dose methotrexate combined with procarbazine and CCNU for primary CNS lymphoma in the elderly: results of a prospective pilot and phase II study.
Topics: Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Comb | 2009 |
14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group.
Topics: Adolescent; Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphami | 2003 |
Combination chemotherapy for small cell carcinoma of the lung: continuous versus alternating non-cross-resistant combinations.
Topics: Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Carcinoma, Small Cell; Cyclophosphamide; Doxoru | 1982 |
Etoposide, vinblastine, and doxorubicin: an active regimen for the treatment of Hodgkin's disease in relapse following MOPP. Cancer and Leukemia Group B.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Doxorubici | 1995 |
[Usefulness of THP-COPBLM therapy in elderly patients with non-Hodgkin's lymphoma].
Topics: Aged; Aged, 80 and over; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclopho | 1997 |
Randomized multicentre trial of filgrastim as an adjunct to combination chemotherapy for Hodgkin's disease. West of Scotland Lymphoma Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Chemotherapy, | 1998 |
Acute hematologic toxicity and practicability of dose-intensified BEACOPP chemotherapy for advanced stage Hodgkin's disease. German Hodgkin's Lymphoma Study Group (GHSG).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Platelets; | 2000 |
Combination chemotherapy of advanced lung cancer: a randomized trial.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Carcinoma, Bronchogenic; Carcinoma, Small Cell; | 1976 |
MVPP chemotherapy combined with radiotherapy in the treatment of Hodgkin's disease in children.
Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Clinical Trials as Topic; Drug Evaluatio | 1978 |
Mechlorethamine, vincristine, and procarbazine chemotherapy for recurrent high-grade glioma in adults: a phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Female; G | 1990 |
Moderate versus aggressive chemotherapy of nodular lymphocytic poorly differentiated lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Female; Follow-Up Stud | 1985 |
29 other studies available for procarbazine and Leukopenia
| Article | Year |
|---|---|
Model-based optimization of G-CSF treatment during cytotoxic chemotherapy.
Topics: Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxo | 2018 |
[Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].
Topics: Adolescent; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; | 2008 |
Intensified PCV-chemotherapy with optional stem cell support in recurrent malignant oligodendroglioma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Brain Neoplasms; Female | 2002 |
Modified ProMACE-MOPP hybrid regimen with moderate-dose methotrexate for patients with primary CNS lymphoma.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Centra | 2005 |
[Comparison of preliminary results of involved-field with extended field radiotherapy combined with chemotherapy for early stage Hodgkin's disease].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 2006 |
Adriamycin, bleomycin, DIC, CCNU, and prednisone (ABDIC) chemotherapy in MOPP-resistant Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bleomycin; Dacarbazine; Doxorubicin; Drug Administra | 1980 |
[Effect of splenectomy on the leukocyte count during the treatment of children with Hodgkin's disease].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Hodgkin Disease | 1984 |
Diffuse aggressive lymphomas: increased survival after alternating flexible sequences of proMACE and MOPP chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bloo | 1983 |
Sequential non-cross-resistant chemotherapy regimens (MOPP and CAVmP) in Hodgkin's disease stage IIIB and IV.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; | 1983 |
The treatment of histiocytic lymphoma.
Topics: Antineoplastic Agents; Cyclophosphamide; Cytarabine; Doxorubicin; Humans; Leucovorin; Leukopenia; Ly | 1980 |
Combination cytotoxic chemotherapy with CCNU, procarbazine, and vincristine in disseminated cutaneous malignant melanoma: 3 years, followup.
Topics: Adult; Aged; Female; Follow-Up Studies; Humans; Leukopenia; Lomustine; Male; Melanoma; Middle Aged; | 1980 |
[Treatment with ACVP-16 for relapsed and refractory non-Hodgkin's lymphoma].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplat | 1993 |
Combinaed chemotherapy with cyclophosphamide, vinblastine, procarbazine, and prednisone (CVPP) for patients with advanced Hodgkin's disease. An alternative program to MOPP.
Topics: Adolescent; Adult; Age Factors; Aged; Alopecia; Antineoplastic Agents; Cyclophosphamide; Drug Therap | 1976 |
[From tumors to scales].
Topics: Agranulocytosis; Humans; Immunologic Deficiency Syndromes; Leg Ulcer; Leukopenia; Male; Mechloretham | 1975 |
[The COP-BLAM therapy for malignant lymphoma].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophos | 1990 |
[Salvage chemotherapy with IMV-triple P for relapsed or refractory malignant lymphoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Drug Evaluation; Female; Hea | 1991 |
Treatment of refractory lymphoma with methotrexate, VM-26 (teniposide), procarbazine, and dexamethasone: Cancer and Leukemia Group B study 7902.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Dexametha | 1988 |
Epirubicin in combination chemotherapy in the treatment of advanced stage non-Hodgkin's lymphomas.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cardiomyopathies; Cyclophosphamide; Doxorubic | 1987 |
A preliminary analysis of combination therapy with vincristine, adriamycin, and prednimustine (VAP) in advanced breast cancer: a phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dac | 1986 |
Procarbazin in advanced malignant melanoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Female; Humans; Leukopenia; M | 1986 |
[Cytostatic therapy of bronchial carcinoma].
Topics: Antineoplastic Agents; Bronchial Neoplasms; Cyclophosphamide; Humans; Leukopenia; Methotrexate; Pall | 1972 |
[Results of polychemotherapy in neoplasms of the lymphoreticular system].
Topics: Antineoplastic Agents; Cyclophosphamide; Hodgkin Disease; Humans; Infections; Leukopenia; Long-Term | 1973 |
Combination chemotherapy in the treatment of advanced Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Benzoates; Female; Hodgkin Disease; Humans; Leukopen | 1973 |
Procarbazine hydrochloride in the treatment of brain tumors. Phase 2 study.
Topics: Adolescent; Adult; Anticonvulsants; Astrocytoma; Brain Neoplasms; Child; Electroencephalography; Epe | 1974 |
Combination chemotherapy with cyclophosphamide, vinblastine, procarbazine and prednisone in the treatment of malignant lymphomas.
Topics: Administration, Oral; Cyclophosphamide; Drug Therapy, Combination; Hodgkin Disease; Humans; Injectio | 1973 |
Treatment of advanced Hodgkin's disease with combination chemotherapy.
Topics: Adult; Antineoplastic Agents; Dactinomycin; Drug Therapy, Combination; Female; Hodgkin Disease; Huma | 1973 |
The use of different drugs and combinations in the treatment of Hodgkin's disease.
Topics: Administration, Oral; Anemia; Drug Evaluation; Drug Therapy, Combination; Hodgkin Disease; Humans; I | 1973 |
Cyclic chemotherapy in lymphoma.
Topics: Adult; Aged; Antineoplastic Agents; Benzoates; Cyclophosphamide; Evaluation Studies as Topic; Female | 1971 |
The haematological response to the immunosuppressive methylhydrazine derivates procarbazine and Ro 4-6824.
Topics: Animals; Antilymphocyte Serum; Antineoplastic Agents; Benzoates; Blood Platelets; Body Weight; Eryth | 1971 |